BioXcel Therapeutics Inc. (BTAI) Surged 7.98% or 0.65 To Price $8.8 On Wednesday


BioXcel Therapeutics Inc. (BTAI) surged 7.98% or 0.65 to $8.8. It is approximately 53836 shares traded, which is 119.02% compare to the average total volume 45231. The market cap of BTAI is $137.68 million. The year to date change is -26.11%. The 52 week price range is from $6.76 to $11.94. Price of BTAI have changed 16.10% during last week. It have changed -19.86% over last month, -26.11% over last 3 months, -26.11% over last 6 months and -26.11% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for BTAI is 9.47. It is 7.61% above current price. The 52-week High is 11.94. It is 35.68% from the current price. The 52-week Low is 6.76. It is -23.18% from current price.

Some people may be interesting about short interest ratio of a stock. The short interest ratio of BTAI is 0.23 on 2018-04-13. Short % to float is 0.08%. There are some statistics of BTAI. It is has market cap $137.68 million. The share outstanding is 15.65 million. The average volume is 45231. The percent of top 15 Institution holding is 1.90%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of BTAI is 671.65%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of BTAI is -666.04%.


Tags:

Share this post